Biology Reference
In-Depth Information
dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet
Neurol 9:77-93
Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA (2007) Dystrophin-deficient mdx
mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
FASEB J 21:2195-2204
Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ,
Tidball JG, Stull JT (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular
dystrophy. Proc Natl Acad Sci USA 93:9142-9147
Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, Hoffman EP,
Chamberlain JS, Bredt DS (1996) Selective loss of sarcolemmal nitric oxide synthase in
Becker muscular dystrophy. J Exp Med 184:609-618
Chao DS, Silvagno F, Xia H, Cornwell TL, Lincoln TM, Bredt DS (1997) Nitric oxide synthase
and cyclic GMP-dependent protein kinase concentrated at the neuromuscular endplate. Neuro-
science 76:665-672
Chenard AA, Becane HM, Tertrain F, de Kermadec JM, Weiss YA (1993) Ventricular arrhythmia
in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord
3:201-206
Chu V, Otero JM, Lopez O, Sullivan MF, Morgan JP, Amende I, Hampton TG (2002) Electrocar-
diographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy.
Muscle Nerve 26:513-519
Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S, Ragone G, Pescatori M,
Zaccagnini G, Antonini A, Minetti G, Martelli F, Piaggio G, Gallinari P, Steinkuhler C,
Clementi E, Dell'Aversana C, Altucci L, Mai A, Capogrossi MC, Puri PL, Gaetano C (2008)
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in
Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA 105:19183-19187
Craven KB, Zagotta WN (2006) CNG and HCN channels: two peas, one pod. Annu Rev Physiol
68:375-401
Crosbie RH, Barresi R, Campbell KP (2002) Loss of sarcolemma nNOS in sarcoglycan-deficient
muscle. FASEB J 16:1786-1791
Danialou G, Comtois AS, Dudley R, Karpati G, Vincent G, Des Rosiers C, Petrof BJ (2001)
Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced
contractile failure and injury. FASEB J 15:1655-1667
Das A, Xi L, Kukreja RC (2008) Protein kinase G-dependent cardioprotective mechanism of
phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem
283:29572-29585
Davies KE, Nowak KJ (2006) Molecular mechanisms of muscular dystrophies: old and new
players. Nat Rev Mol Cell Biol 7:762-773
de Kermadec JM, B´cane HM, Ch´nard A, Tertrain F, Weiss Y (1994) Prevalence of left
ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic
study. Am Heart J 127:618-623
Dellorusso C, Crawford RW, Chamberlain JS, Brooks SV (2001) Tibialis anterior muscles in mdx
mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 22:467-475
Eagle M, Bourke J, Bullock R, Gibson M, Mehta J, Giddings D, Straub V, Bushby K (2007)
Managing Duchenne muscular dystrophy-the additive effect of spinal surgery and home
nocturnal ventilation in improving survival. Neuromuscul Disord 17:470-475
Ervasti JM (2007) Dystrophin, its interactions with other proteins, and implications for muscular
dystrophy. Biochim Biophys Acta 1772:108-117
Ervasti JM, Campbell KP (1993) Dystrophin and the membrane skeleton. Curr Opin Cell Biol
5:82-87
Eu JP, Sun J, Xu L, Stamler JS, Meissner G (2000) The skeletal muscle calcium release channel:
coupled O2 sensor and NO signaling functions. Cell 102:499-509
Fernhoff NB, Derbyshire ER, Marletta MA (2009) A nitric oxide/cysteine interaction mediates the
activation of soluble guanylate cyclase. Proc Natl Acad Sci USA 106:21602-21607
